| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.44 | 0.005 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |